MARKHAM, Ontario--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by Health Canada, in-warranty t:slim X2™ ...

Abbott’s latest innovation, the FreeStyle Libre® 2 Plus sensor, is available for the first time for t:slim X2™ insulin pump users in the U.S. Tandem’s Control-IQ™ hybrid closed-loop technology now ...

The t:slim X2™ insulin pump from Tandem Diabetes Care is now compatible with Abbott’s FreeStyle Libre 3 Plus CGM sensor in ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced U.S. Food and Drug Administration (FDA) clearance of ...

It takes two: After making its commercial debut early this year, Dexcom’s latest continuous glucose monitor is wrapping up 2023 by connecting with its first automated insulin pump partner, courtesy of ...

Tandem has finally made its long-awaited app-based Mobile Bolus feature available to insulin pump users thanks to a newly-released set of updates. We tried it ourselves to see how the first ...

Tandem Diabetes Care, Insulet and Dexcom all presented data over the weekend at the American Diabetes Association’s ...

Tandem Diabetes Care (TNDM) announced on Friday that the European Union has issued the CE mark, expanding the indications for its automated insulin delivery systems, t:slim X2 and Tandem Mobi in ...

Tandem Diabetes Care has announced that its t X2 insulin pump with Control-IQ+ automated insulin delivery technology is now compatible with Abbott’s FreeStyle Libre 3 Plus continuous glucose monitorin ...

Tandem Diabetes' Q1 beat, fatter margins and positive cash flow fuel its 2026 reset as it shifts more U.S. pump starts to pay-as-you-go pharmacy.

“The commercial availability of this new offering is a testament to our decade-long partnership with Dexcom and shared commitment to continued leadership in advancing AID systems,” said Mark Novara, ...